臨床試驗

AVAVA MIRIA General Use

NCT：NCT06868615 · RECRUITING

NCT IDNCT06868615

狀態RECRUITING

開始日期2024-09-11

完成時間2027-12-30

SponsorAVAVA, Inc. (INDUSTRY)

First posted2025-03-11

Last updated2026-09-15

簡要摘要

A general protocol to treat a variety of dermatologic conditions and collect patient feedback. Primary outcome is the collection and analysis of patient questionnaires related to the overall experience of the device treatment. Secondary outcome measures include physician and subject evaluations in regards to improvement seen in the device as well as assessment of side effects.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。